Suppr超能文献

促甲状腺激素升高与甲状腺功能正常者及亚临床甲状腺功能减退患者血清催乳素升高有关。

Increase in Thyrotropin Is Associated with an Increase in Serum Prolactin in Euthyroid Subjects and Patients with Subclinical Hypothyroidism.

作者信息

Sheikhi Vahid, Heidari Zahra

机构信息

Department of Pediatric Nephrology, Zahedan University of Medical Sciences, Zahedan, Iran.

Department of Endocrinology and Metabolism, Zahedan University of Medical Sciences, Zahedan, Iran.

出版信息

Med J Islam Repub Iran. 2021 Dec 15;35:167. doi: 10.47176/mjiri.35.167. eCollection 2021.

Abstract

Prevalence and clinical significance of hyperprolactinemia in subclinical hypothyroidism have been reported in few studies. The upper limit of the normal range for TSH used to diagnose subclinical hypothyroidism is a matter of controversy. Some experts believe that the upper limit of the normal TSH range should be reduced from 4.2 to 2.5 mIU/L. Some evidence suggests a positive relationship between TSH > 2.5 mIU/L and cortisol as an indicator of metabolic stress. With this view prolactin as a stress hormone can be elevated in TSH >2.5 in comparison to TSH< 2.5. Hence the aim of this study was to evaluate the relationship between TSH and prolactin levels in the TSH range <10. This cross-sectional study was performed on apparently healthy subjects with TSH<10 mIU/L. Subjects with the age of 18 to 35 years were enrolled. The sera were analyzed for prolactin, FT3, FT4, TSH, TPO-Ab and Tg-Ab. From the total number of 519 participants, in 65 subjects (12.5%) TSH was < 2.5. Seventy-nine subjects (15.2%) had TSH: 2.5-4.2 and 375 (72.3%) of the participants had TSH> 4.2 mIU/L. The mean age, weight and BMI of subjects in the three TSH groups were not significantly different. In the three TSH groups, the prevalence of hyperprolactinemia was zero, 3.8 and 30.7%, respectively. There was a positive and significant correlation between prolactin and TSH levels (r=0.613). Hyperprolactinemia is common in patients with subclinical hypothyroidism (30.7%) and there is a positive correlation between TSH and PRL in subjects with TSH<10 mIU/l.

摘要

关于亚临床甲状腺功能减退症患者高催乳素血症的患病率及其临床意义,仅有少数研究进行过报道。用于诊断亚临床甲状腺功能减退症的促甲状腺激素(TSH)正常范围上限存在争议。一些专家认为,TSH正常范围上限应从4.2 mIU/L降至2.5 mIU/L。一些证据表明,TSH>2.5 mIU/L与作为代谢应激指标的皮质醇之间存在正相关关系。基于此观点,与TSH<2.5相比,TSH>2.5时作为应激激素的催乳素可能会升高。因此,本研究的目的是评估TSH范围<10时TSH与催乳素水平之间的关系。本横断面研究针对TSH<10 mIU/L的表面健康受试者开展。纳入年龄在18至35岁之间的受试者。对血清进行催乳素、游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、TSH、甲状腺过氧化物酶抗体(TPO-Ab)和甲状腺球蛋白抗体(Tg-Ab)分析。在总共519名参与者中,65名受试者(12.5%)的TSH<2.5。79名受试者(15.2%)的TSH为2.5 - 4.2,375名(72.3%)参与者的TSH>4.2 mIU/L。三个TSH组受试者的平均年龄、体重和体重指数无显著差异。在三个TSH组中,高催乳素血症的患病率分别为零、3.8%和30.7%。催乳素与TSH水平之间存在显著正相关(r = 0.613)。高催乳素血症在亚临床甲状腺功能减退症患者中很常见(30.7%),且在TSH<10 mIU/l的受试者中TSH与PRL之间存在正相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/824d/9034874/c749f3284383/mjiri-35-167-g001.jpg

相似文献

2
Assessment of serum cortisol and thyrotropin correlation in euthyroid and subclinical hypothyroid subjects.
Expert Rev Endocrinol Metab. 2021 Sep;16(5):263-269. doi: 10.1080/17446651.2021.1968829. Epub 2021 Aug 17.
3
"Hypothyroidism screening during first trimester of pregnancy".
BMC Pregnancy Childbirth. 2017 Dec 22;17(1):438. doi: 10.1186/s12884-017-1624-x.
5
Comparison of Five Different Criteria for Diagnosis of Subclinical Hypothyroidism in a Large-Scale Chinese Population.
Front Endocrinol (Lausanne). 2022 Feb 15;13:820414. doi: 10.3389/fendo.2022.820414. eCollection 2022.
6
Hyperprolactinemia in Children with Subclinical Hypothyroidism.
J Clin Res Pediatr Endocrinol. 2017 Dec 15;9(4):350-354. doi: 10.4274/jcrpe.4536. Epub 2017 May 22.
7
A cross-sectional survey of relationship between serum TSH level and blood pressure.
J Hum Hypertens. 2010 Feb;24(2):134-8. doi: 10.1038/jhh.2009.44. Epub 2009 Jun 25.
9
Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism.
Eur J Intern Med. 2016 Nov;35:106-110. doi: 10.1016/j.ejim.2016.07.012. Epub 2016 Jul 26.

引用本文的文献

本文引用的文献

1
TSH Levels in Subclinical Hypothyroidism in the 97.5th Percentile of the Population.
Int J Endocrinol. 2020 Jun 13;2020:2698627. doi: 10.1155/2020/2698627. eCollection 2020.
2
Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction.
J Thyroid Res. 2019 Sep 22;2019:4106816. doi: 10.1155/2019/4106816. eCollection 2019.
3
Thyroid hormone therapy for subclinical hypothyroidism.
Endocrine. 2019 Oct;66(1):27-34. doi: 10.1007/s12020-019-02039-z. Epub 2019 Oct 15.
4
Subclinical Hypothyroidism: A Review.
JAMA. 2019 Jul 9;322(2):153-160. doi: 10.1001/jama.2019.9052.
5
Diagnosis, misdiagnosis and management of hyperprolactinemia.
Expert Rev Endocrinol Metab. 2006 Jan;1(1):123-132. doi: 10.1586/17446651.1.1.123.
6
The forgotten effects of thyrotropin-releasing hormone: Metabolic functions and medical applications.
Front Neuroendocrinol. 2019 Jan;52:29-43. doi: 10.1016/j.yfrne.2018.06.006. Epub 2018 Jun 22.
7
Global epidemiology of hyperthyroidism and hypothyroidism.
Nat Rev Endocrinol. 2018 May;14(5):301-316. doi: 10.1038/nrendo.2018.18. Epub 2018 Mar 23.
8
Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism.
Eur J Intern Med. 2016 Nov;35:106-110. doi: 10.1016/j.ejim.2016.07.012. Epub 2016 Jul 26.
10
Evaluation of serum prolactin level in patients of subclinical and overt hypothyroidism.
J Clin Diagn Res. 2015 Jan;9(1):BC15-7. doi: 10.7860/JCDR/2015/9982.5443. Epub 2015 Jan 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验